NCT01410903 - Immunoadsorption in Patients With Severe Systemic Sclerosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

August 31, 2012

Conditions

Systemic Scleroderma

Interventions

DEVICE

TheraSorb Ig

1,5 plasma volume per treatment venovenous immunoadsorption frequency: three times weekly in week 1 and 2, two times weekly in week 3-6, two times two-weekly in week 7-12 duration: 12 months

Trial Locations (1)

01307

Universitätsklinikum Dresden, Dresden